Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?

Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?

Submitted by admin on August 26, 2021 - 11:02am
Source: 
Motley Fool
News Tags: 
Rigel Pharmaceuticals
Emergency Use Authorization
FDA
Tavalisse
COVID-19
Headline: 
Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?
snippet: 
  • The FDA recently refused to grant an EUA for Rigel's Tavalisse in treating COVID-19.
  • Rigel's EUA submission was based on phase 2 results; the FDA wants more data from a phase 3 study.

Do Not Allow Advertisers to Use My Personal information